DYNACARD MARKETING PTE LTD
UEN: 199202181K
DYNACARD MARKETING PTE LTD(199202181K) is a Singapore business with registered business address at 3006 UBI ROAD 1, 4-394, KAMPONG UBI INDUSTRIAL ESTATE, Singapore 408700. They specialise in the area of MANUFACTURE AND REPAIR OF MACHINERY FOR BEVERAGE PRODUCTION and WHOLESALE TRADE OF A VARIETY OF GOODS WITHOUT A DOMINANT PRODUCT.
| Company Name | DYNACARD MARKETING PTE LTD |
| Unique Entity Number | 199202181K |
| Entity Type | Local Company |
| Entity Status | Live Company |
| Incorporate Day | 28 April 1992 |
| Address |
3006 UBI ROAD 1 #4-394 KAMPONG UBI INDUSTRIAL ESTATE Singapore 408700 |
| Products / Services |
MANUFACTURE AND REPAIR OF MACHINERY FOR BEVERAGE PRODUCTION WHOLESALE TRADE OF A VARIETY OF GOODS WITHOUT A DOMINANT PRODUCT |
| Number of Officers | 3 |
| Paid Up Capital | SGD 30000 |
Breaking! Business News
Congenica and Camtech Diagnostics agree strategic partnership to support genomic analysis platform expansion in AsiaCongenica and Camtech Diagnostics agree strategic partnership to support genomic analysis platform e...
Read More
Giving Back, Changing Lives: inCruises Partners with Mercy Ships to Transform Lives in AfricaGiving Back, Changing Lives: inCruises Partners with Mercy Ships to Transform Lives in AfricaGlobeN...
Read More
Immunocore presents phase 3 data comparing tebentafusp with investigator’s choice in the clinical trial plenary session at the American Association for Cancer Research 2021 Annual MeetingImmunocore presents phase 3 data comparing tebentafusp with investigator’s choice in the clinical ...
Read More
Global Smart Commodity Group to host Aloe Contracts on Salus PlatformGlobal Smart Commodity Group to host Aloe Contracts on Salus PlatformGlobeNewswireApril 12, 2021CHIC...
Read More
IIA Signs MOU with Vietnam’s Ministry of FinanceIIA Signs MOU with Vietnam’s Ministry of FinanceCollaboration focuses on furthering the mission of...
Read More
NMPA Approves Toripalimab in Patients with Locally Advanced or Metastatic Urothelial Carcinoma who Failed Platinum-Containing Chemotherapy or Progressed within 12 Months of Neoadjuvant or Adjuvant Platinum-Containing ChemotherapyNMPA Approves Toripalimab in Patients with Locally Advanced or Metastatic Urothelial Carcinoma who F...
Read More
Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone fo...
Read More
Colliers releases first Global Impact ReportColliers releases first Global Impact ReportDevelopment of full impact position and comprehensive st...
Read More